Acquisition by Nardo Christopher J of 100000 shares of Dermata Therapeutics subject to Rule 16b-3

DRMA Stock  USD 1.20  0.05  4.00%   
About 62% of Dermata Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Dermata Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Dermata Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Dermata Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Dermata Therapeutics Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Dermata insider trading alert for grant of stock option right to buy by Nardo Christopher J, Senior VP CDO, on 18th of April 2023. This event was filed by Dermata Therapeutics Inc with SEC on 2023-01-05. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Dermata Therapeutics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Dermata Therapeutics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Dermata Therapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Dermata Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Dermata Therapeutics Fundamental Analysis

We analyze Dermata Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dermata Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dermata Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Dermata Therapeutics is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Dermata Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dermata Therapeutics stock to make a market-neutral strategy. Peer analysis of Dermata Therapeutics could also be used in its relative valuation, which is a method of valuing Dermata Therapeutics by comparing valuation metrics with similar companies.

Peers

Dermata Therapeutics Related Equities

EDITEditas Medicine   4.69   
0%
56.0%
REGNRegeneron Pharmaceuticals   1.43   
0%
17.0%
SRPTSarepta Therapeutics   1.32   
0%
16.0%
BEAMBeam Therapeutics   1.18   
0%
14.0%
NVONovo Nordisk   0.40   
0%
4.0%
CRBUCaribou Biosciences   3.13   
37.0%
0%
FATEFate Therapeutics   4.23   
51.0%
0%
HEPAHepion Pharmaceuticals   5.88   
71.0%
0%
NTLAIntellia Therapeutics   6.95   
84.0%
0%
VERVVerve Therapeutics   8.25   
100.0%
0%

Complementary Tools for Dermata Stock analysis

When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals